An unexpected finding in preclinical platelet studies could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.
New drug brings unexpected hope in targeting cancer cells
An unexpected finding in preclinical platelet studies could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.